reviewNature reviews. CancerApr 15, 2016GREEN OA

Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy

SLSuzanne L. Topalian JMJanis M. Taube RARobert A. Anders DMDrew M. Pardoll

Johns Hopkins University · Bloomberg (United States) · +1 more institution

Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

2,718

total citations

FWCI: 129.23
Percentile: 100%
References: 128

Citations per year

Authors

4

SL
Suzanne L. TopalianCorresponding
Johns Hopkins University, Bloomberg (United States), Sidney Kimmel Comprehensive Cancer Center
JM
Janis M. Taube
Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Bloomberg (United States)
RA
Robert A. Anders
Bloomberg (United States), Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University
DM
Drew M. Pardoll
Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, Bloomberg (United States)

Topics & keywords

Topics

Keywords

Immune checkpoint
Blockade
Immune system
Cancer
Medicine
Biomarker
Melanoma
Mechanism (biology)

UN Sustainable Development Goals

Good health and well-being

No related works found for this paper.